Aspen Makes Play For GSK Thrombosis Drugs, Facility

Law360, New York (June 18, 2013, 1:28 PM EDT) -- Aspen Pharmacare Holdings Ltd., which has a history of snapping up GlaxoSmithKline PLC's less-profitable drugs, has made an offer to purchase two of the pharmaceutical giant's thrombosis drug brands and a manufacturing facility in France, according to Tuesday statements.

GSK and South Africa-based Aspen, which made the offer jointly with affiliate Aspen Global Inc., are negotiating a possible deal and declined to disclose financial details of the bid offer, according to investor documents. The companies have agreed to a period of exclusivity, GSK said.

At stake...
To view the full article, register now.